CMV IGG Antibodies in Semen as a Predictor for Blood Testis Barrier Damage
Clinical trial NCT05302856 · UNKNOWN
Trial details
- NCT number
- NCT05302856
- Sponsor
- Hadassah Medical Organization
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-02
- Primary completion
- 2023-03-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.